Related Experiment Videos

The development of asthma in wheezing infants with Chlamydia pneumoniae infection

Masafumi Zaitsu1

  • 1Department of Pediatrics, Faculty of Medicine, Saga University, Saga, Japan. zaitsum@cc.saga-u.ac.jp

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|September 22, 2007
PubMed

Insights

Chlamydia pneumoniae infection may trigger asthma in infants. This study found wheezing infants infected with Chlamydia pneumoniae were more likely to develop asthma within a year.

Area of Science:

  • Pediatric respiratory health
  • Infectious disease pathology
  • Asthma research

Background:

  • The link between Chlamydia pneumoniae infection and asthma is known, but its specific role in infantile asthma is unclear.
  • Investigating early-life infections is crucial for understanding asthma development.
  • Wheezing in infancy is a significant risk factor for developing asthma.

Purpose of the Study:

  • To investigate the association between Chlamydia pneumoniae infection and the development of asthma in wheezing infants.
  • To determine if Chlamydia pneumoniae infection acts as a trigger for asthma in early childhood.
  • To clarify the role of Chlamydia pneumoniae in the pathology of infantile asthma.

Main Methods:

  • Serological testing was used to detect Chlamydia pneumoniae infection in a cohort of wheezing infants.
  • Infants were followed for one year, with reassessment to diagnose asthma.
  • A comparative analysis was conducted between infected and non-infected infants regarding asthma progression.

Main Results:

  • Wheezing infants diagnosed with Chlamydia pneumoniae infection showed a higher progression rate to asthma compared to uninfected infants.
  • A statistically significant association was observed between Chlamydia pneumoniae infection and the development of asthma.
  • The findings indicate a potential causal link between the infection and asthma onset in this population.

Conclusions:

  • Chlamydia pneumoniae infection is suggested to be a trigger for asthma development in wheezing infants.
  • Early detection and management of Chlamydia pneumoniae infections may be important in preventing asthma in susceptible infants.
  • Further research is warranted to explore therapeutic strategies targeting Chlamydia pneumoniae in infantile asthma.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma